Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hoffmann

Showing results (531-540 of 566) with videos related to

Pageof 57
Sort By:
Anais Da Academia Brasileira De Ciencias|November 29, 2019
Weathering Resistance of Waterborne Polyurethane Coatings Reinforced with Silica from Rice Husk AshWesley F Monteiro, Gabriela M Miranda, Rafael R Soares, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|September 26, 2022
Disentangling the influences of parental genetics on offspring's cognition, education, and psychopathology via genetic and phenotypic pathwaysLuiza K Axelrud, Maurício S Hoffmann, Daniel E Vosberg, et al.
Blood Advances|February 5, 2025
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 studyJason Westin, Tycel J Phillips, Amitkumar Mehta, et al.
Blood Advances|August 15, 2023
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 studyAdam J Olszewski, Tycel J Phillips, Marc S Hoffmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2014
The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunityFranziska S Hoffmann, Peer-Hendrik Kuhn, Sarah A Laurent, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 12, 2019
Delayed creatine supplementation counteracts reduction of GABAergic function and protects against seizures susceptibility after traumatic brain injury in ratsRogerio R Gerbatin, Luiz Fernando Almeida Silva, Maurício S Hoffmann, et al.
American Journal of Hematology|August 29, 2019
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobinMichael Lauseker, Katharina Bachl, Anna Turkina, et al.
Nature Communications|June 13, 2015
γ-Secretase directly sheds the survival receptor BCMA from plasma cellsSarah A Laurent, Franziska S Hoffmann, Peer-Hendrik Kuhn, et al.
Nature|October 16, 2014
Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptorsThorsten Gnad, Saskia Scheibler, Ivar von Kügelgen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML IntergroupThomas Büchner, Richard F Schlenk, Markus Schaich, et al.
Pageof 57

Showing results (531-540 of 566) with videos related to

Sort By:
Pageof 57
Anais Da Academia Brasileira De Ciencias|November 29, 2019
Weathering Resistance of Waterborne Polyurethane Coatings Reinforced with Silica from Rice Husk AshWesley F Monteiro, Gabriela M Miranda, Rafael R Soares, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|September 26, 2022
Disentangling the influences of parental genetics on offspring's cognition, education, and psychopathology via genetic and phenotypic pathwaysLuiza K Axelrud, Maurício S Hoffmann, Daniel E Vosberg, et al.
Blood Advances|February 5, 2025
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 studyJason Westin, Tycel J Phillips, Amitkumar Mehta, et al.
Blood Advances|August 15, 2023
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 studyAdam J Olszewski, Tycel J Phillips, Marc S Hoffmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2014
The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunityFranziska S Hoffmann, Peer-Hendrik Kuhn, Sarah A Laurent, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 12, 2019
Delayed creatine supplementation counteracts reduction of GABAergic function and protects against seizures susceptibility after traumatic brain injury in ratsRogerio R Gerbatin, Luiz Fernando Almeida Silva, Maurício S Hoffmann, et al.
American Journal of Hematology|August 29, 2019
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobinMichael Lauseker, Katharina Bachl, Anna Turkina, et al.
Nature Communications|June 13, 2015
γ-Secretase directly sheds the survival receptor BCMA from plasma cellsSarah A Laurent, Franziska S Hoffmann, Peer-Hendrik Kuhn, et al.
Nature|October 16, 2014
Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptorsThorsten Gnad, Saskia Scheibler, Ivar von Kügelgen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML IntergroupThomas Büchner, Richard F Schlenk, Markus Schaich, et al.
Pageof 57